HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases

Cancer Gene Therapy, Published online: 03 June 2019; doi:10.1038/s41417-019-0104-zHITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases

Source: Cancer Gene Therapy - June 2, 2019 Category: Cancer & Oncology Authors: Steven C. Katz John Hardaway Ethan Prince Prajna Guha Marissa Cunetta Ashley Moody Li Juan Wang Vincent Armenio N. Joseph Espat Richard P. Junghans Source Type: research